Target intelligence / Profile preview

ribosomal protein L21 pseudogene 107 (RPL21P107)

Target
RPL21P107
Molecular classification
Other, pseudogene
01

Overview

RPL21P107 is a processed pseudogene of the ribosomal protein L21 gene in humans. Pseudogenes are typically non-functional DNA sequences that resemble known genes but do not encode functional proteins. RPL21P107 is not expressed as a protein and does not have known biological functions, disease roles, or drug interactions. It is classified as a pseudogene and does not function as an enzyme, receptor, transporter, or therapeutic target[3][5][7]. The canonical, functional gene is RPL21, which codes for a component of the 60S ribosomal subunit, essential for protein synthesis in the cytoplasm[1][2]. There are numerous ribosomal protein pseudogenes dispersed throughout the human genome, including RPL21P107[1][2].\n\nKey points:\n- This entry is a pseudogene and not a therapeutic target.\n- No known disease association, molecular activity, or drug interaction.\n- The correct molecular classification is "Other" (specifically, pseudogene).\n- The entry may be misleading if interpreted as a functional target; thus, is_incorrect: true applies for drug/discovery targeting purposes.

Other names
RPL21_46_1336RPL21P107

Beyond the preview

Go deeper on ribosomal protein L21 pseudogene 107 (RPL21P107).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ribosomal protein L21 pseudogene 107 (RPL21P107).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call